Marine Compounds and Cancer 2020 - Couverture rigide

Couverture rigide

ISBN 10 : 3036506306 ISBN 13 : 9783036506302

Editeur : Mdpi AG, 2021

Synopsis

The very first marine-derived anticancer drug, Cytarabine (aka Ara-C, Cytosar-U(R)), was approved by the FDA in 1969 for the treatment of leukemia. At the beginning of 2021, the list of approved marine-derived anticancer drugs consists of nine substances, five of which received approval within the last two years, demonstrating the rapid evolution of the field. The current book is a collection of scientific articles related to the exponentially growing field of anticancer marine compounds. These articles cover the whole field, from agents with cancer-preventive activity, to novel and previously characterized compounds with anticancer activity, both in vitro and in vivo, as well as the latest status of compounds under clinical development.

Détails de l'édition

• Éditeur: Mdpi AG
• Date d'édition: 2021
• Langue: anglais
• ISBN 10: 3036506306
• ISBN 13: 9783036506302
• Reliure: Relié
• Nombre de pages: 480
• Éditeur: Honecker Friedemann, Dyshlovoy Sergey A
• Coordonnées du fabricant: non disponible
• Personne responsable: non disponible